Related Experiment Video
Updated: May 18, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Thiazide diuretics in advanced chronic kidney disease
1Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, IN 46202, USA. ragarwal@iupui.edu
Insights
Thiazide diuretics may help control high blood pressure in advanced chronic kidney disease (CKD). Further research is needed to confirm their effectiveness and safety in this population.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Hypertension is common in chronic kidney disease (CKD), often poorly controlled with existing medications.
- Hypervolemia is a key driver of hypertension in CKD, making diuretics a crucial treatment.
- Novel mechanisms like non-osmotic sodium storage in skin and muscle may influence hypertension in CKD.
Purpose of the Study:
- To evaluate the potential role of thiazide diuretics in managing hypertension in advanced chronic kidney disease.
- To review existing literature on thiazide efficacy and safety in stage 4 and advanced CKD.
- To determine if thiazides could be a viable option despite current recommendations favoring loop diuretics.
Main Methods:
- Literature review of observational studies and randomized trials on thiazide diuretic use in advanced CKD.
- Analysis of data on sodium balance, weight changes, and blood pressure reduction associated with thiazides.
- Examination of reported adverse effects and monitoring parameters.
Main Results:
- Observational studies suggest thiazides induce negative sodium balance, leading to 10%-15% increased sodium excretion and 1-2 kg weight loss.
- Blood pressure improvements of 10-15 mm Hg systolic and 5-10 mm Hg diastolic were observed in clinic settings.
- Randomized trials indicated approximately 15 mm Hg improvement in mean arterial pressure.
Conclusions:
- Thiazide diuretics show potential for improving blood pressure control in advanced CKD.
- Adverse effects such as volume depletion, electrolyte imbalances, and acute kidney injury require close monitoring.
- Larger, adequately powered randomized trials are necessary to establish firm recommendations for thiazide use in advanced CKD.
Abstract:
Chronic kidney disease (CKD) is prevalent in 3%-4% of the adult population in the United States, and the vast majority of these people are hypertensive. Compared with those with essential hypertension, hypertension in CKD remains poorly controlled despite the use of multiple antihypertensive drugs. Hypervolemia is thought to be a major cause of hypertension, and diuretics are useful to improve blood pressure control in CKD. Non-osmotic storage of sodium in the skin and muscle may be a novel mechanism by which sodium may modulate hypertension; further work is need to study this novel phenomenon with diuretics. Among people with stage 4 CKD, loop diuretics are recommended over thiazides. Thiazide diuretics are deemed ineffective in people with stage 4 CKD. Review of the literature suggests that thiazides may be useful even among people with advanced CKD. They cause a negative sodium balance, increasing sodium excretion by 10%-15% and weight loss by 1-2 kg in observational studies. Observational data show improvement in seated clinic blood pressure of about 10-15 mm Hg systolic and 5-10 mm Hg diastolic, whereas randomized trials show about 15 mm Hg improvement in mean arterial pressure. Volume depletion, hyponatremia, hypokalemia, hypercalcemia, and acute kidney injury are adverse effects that should be closely monitored. Our review suggests that adequately powered randomized trials are needed before the use of thiazide diuretics can be firmly recommended in those with advanced CKD.
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Heart Failure Drugs: Diuretics
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Antihypertensive Drugs: Potassium-Sparing Diuretics
